BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases.
$0.90+6.19%
报价 2026-11-09
市值
$13.7M
EV
$11.9M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -38.6%
$0.77$1.47
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| BCDABioCardia, Inc. | $13.7M | +6.2% | 0.0% | 0% | – | – | – | |
| PHIOPhio Pharmaceuticals Corp. | $9.8M | +4.8% | -100.0% | 0% | – | – | – | |
| INABIN8bio, Inc. | $9.3M | +1.5% | +418.5% | 0% | – | – | – | |
| ALZNAlzamend Neuro, Inc. | $6.9M | +0.7% | – | 0% | – | – | – | |
| KPRXKiora Pharmaceuticals, Inc. | $6.7M | +4.9% | 0.0% | 0% | – | – | – | |
| APREAprea Therapeutics, Inc. | $6.3M | -3.2% | +266.7% | 0% | – | – | – | |
| ACXPAcurx Pharmaceuticals, Inc. | $5.9M | +12.1% | -97.1% | 0% | – | – | – | |
| APVOAptevo Therapeutics Inc. | $2.5M | -8.9% | +141.9% | 0% | – | – | – | |
| CELZCreative Medical Technology Holdings, Inc. | $1.6M | -1.6% | +779900.0% | -1,732.4% | – | – | – | |
| 同行中位数 | – | – | +141.9% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。